June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Ahmed Kotb: Bispecific Antibodies vs. CAR-T for Relapsed/Refractory Follicular Lymphoma
Jan 30, 2025, 17:32

Ahmed Kotb: Bispecific Antibodies vs. CAR-T for Relapsed/Refractory Follicular Lymphoma

Ahmed Kotb, Hematologist and Bone marrow transplanter at King Faisal Specialist Hospital International Holding Company, shared a post on X:

Bispecific Antibodies vs. CAR-T for Relapsed/Refractory Follicular Lymphoma

BsAb

Off-the-shelf, outpatient, low toxicity

Possible indefinite treatment

CAR-T

Very high CR, long PFS, curative potential

Neurotoxicity risk,long wait time.

Ahmed Kotb: Bispecific Antibodies vs. CAR-T for Relapsed/Refractory Follicular Lymphoma